Cumberland Pharmaceuticals Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent
Cumberland Pharmaceuticals Inc. (CPIX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent of 0.00% for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-09.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2015-03-09
- Cumberland Pharmaceuticals Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2014 was 0.00%.
- Cumberland Pharmaceuticals Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2013 was 0.00%.
- Cumberland Pharmaceuticals Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2012 was -5.00%, a 350.00% decline from fiscal 2011.
- Cumberland Pharmaceuticals Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2011 was 2.00%, a 50.00% decline from fiscal 2010.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month |
|---|---|
| 2014-12-31 | 0.00% 10-K · filed 2015-03-09 |
| 2013-12-31 | 0.00% 10-K · filed 2015-03-09 |
| 2012-12-31 | -5.00% 10-K · filed 2015-03-09 |
| 2011-12-31 | 2.00% 10-K · filed 2014-03-11 |
| 2010-12-31 | 4.00% 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |